Battle stations

  05 January 2020

One morning, Renuka Arora, a 50-year-old regional marketing manager, woke up with red, swollen eyes. The sudden itchiness confounded her, since neither eye had shown any symptom the previous evening. Fearing that it might be a case of conjunctivitis, she wore dark glasses. However, the general physician in her neighbourhood diagnosed it as an eye infection and prescribed Ciplox, an antibiotic. Within 24 hours, the infection had cleared. But was there a need for an antibiotic in the first place, asks Dr Siddharth Chopra, senior scientist and microbiologist, Central Drug Research Institute (CSIR-CDRI), Lucknow.

 

Further reading: The Week
Author(s): Pooja Biraia Jaiswal
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed